ESC 365 - Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra

ESC2025 Premium Access

Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra

Session: Biomarkers and prognosis in acute heart failure

Topic: Pharmacotherapy

Speaker: Doctor A. Abbate (Charlottesville, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Antonio Abbate

University of Virginia, Charlottesville (United States of America)

3 presentations

0 follower

7 more presentations in this session

Association between high serum uric acid and poor outcomes in patients with acute heart failure.

Speaker: Doctor F. Qorina (Oxford, GB)

Diagnostic and prognostic performance of insulin-like growth factor-binding protein 7 in patients with acute dyspnea in the emergency department

Speaker: Ms C. Popescu (Basel, CH)

Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study

Speaker: Ms E. Ghanbari (Berlin, DE)

The role of exhaled breath acetone and BNP in predicting outcomes in advanced heart failure

Speaker: Doctor D. Costa-Dan (Sao Paulo, BR)

Admission natriuresis as a predictor of outcomes in acute decompensated heart failure

Speaker: Mr J. Iroulart (Buenos Aires, AR)

Access the full session

Biomarkers and prognosis in acute heart failure

Speakers: Doctor A. Abbate, Doctor F. Qorina, Ms C. Popescu, Ms E. Ghanbari, Doctor D. Costa-Dan...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources